Islet hormone secretion in pancreatic cancer patients with diabetes

Pancreas

Volumn 15, Issue 1, 1997, Pages 60-68

  Permert, J ^a,b   Larsson, J ^b   Fruin, A B ^a   Tatemoto, K ^d   Herrington, M K ^a   Von Schenck, H ^c   Adrian, T E ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d NONE

Author keywords

Endocrine pancreatic function; Exocrine pancreatic adenocarcinoma; Hyperglycemic glucose clamp; Islet hormones; Subtotal pancreatectomy

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; PANCREAS POLYPEPTIDE; PANCREASTATIN; SOMATOSTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; FEMALE; GLUCOSE CLAMP TECHNIQUE; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS RESECTION; PRIORITY JOURNAL;

EID: 0030707586     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199707000-00009     Document Type: Article

References (34)

1. Schwarz SS, Zeidler A, Moossa AR, Kuku SF, Rubenstein AH. A prospective study of glucose tolerance, insulin C-peptide, and glucagon responses in patients with pancreatic carcinoma. Dig Dis 1978;23:1107-14.
2. Permert J, Ihse I, Jorfeldt L, Arnquist H, von Schenck H, Larsson J. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993;159:101-7.
3. Cersosimo E, Pisters P, Pesola G, McDermott K, Bajorunas D, Brennan MF. Insulin secretion and action in patients with pancreatic cancer. Cancer 1991;67:468-93.
4. Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB, Larsson J. Is the profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor associated factor? Am J Surg 1993;165:61-7.
5. Koskinen P, Viikari J, Irjala K, Kaihola H-A, Seppälä P. Plasma and urinary C-peptide in the classification of adult diabetes. Scand J Clin Lab Invest 1986;46:655-62.
6. Turner RC, Williamson DH. Control of metabolism and the alterations in diabetes. In: O'Riordan JLH, ed. Recent advances in endocrinology and metabolism, Vol. 2. Edinburgh: Churchill Livingstone; 1982:73-97.
7. Ingelfinger FJ. The diagnosis of cancer of the pancreas. N Engl J Med 1946;235:653-61.
8. Permert J, Larsson J, Westermark GT, Pour PM, Westermark P, Adrian TE. Diabetes in pancreatic cancer patients is associated with excessive pancreatic islet amyloid polypeptide release. N Engl J Med 1994;330:313-8.
9. Adrian TE, Bloom SR, Hermansen K, Iversen J. Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas. Diabetologia 1978;14:413-7.
10. Unger RH. The milieu intérieur and the islets of Langerhans. Diabetologia 1981;20:1-11.
11. Permert J, Mogaki M, Andrén-Sandberg A, Kazakoff K, Pour PM. Pancreatic mixed ductal-islet tumors - Is this an entity? Int J Pancreatol 1992;2:23-9.
12. Kodama T, Mori W. Morphological behaviour of carcinoma of the pancreas. Agyrophil cells and Langerhans' islets in the carcinomatous tissue. Acta Pathol Jpn 1983;33:483-93.
13. Unger RH, Orci L. Glucagon and the A cell. N Engl J Med 1981;304:1575-82.
14. Aguilar-Parada E, Eisentraut AM, Linger RH. Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 1981;6:415-9.
15. Davies RR, Miller M, Turner SJ, et al. Effects of somatostatin analogue SMS 201-995 in normal man. Clin Endocrinol (Oxf) 1986;24:665-74.
16. Sowa R, Sanke T, Hirayama J, et al. Islet amyloid polypeptide amide causes peripheral insulin resistance in vivo in dogs. Diabetologia 1990;33:118-20.
17. Leighton B, Cooper GJS. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 1988;335:632-5.
18. Permert J, Jorfeldt L, von Schenck H, Ihse I, Larsson J. Glucose metabolism improved in patients with pancreatic cancer after subtotal pancreatectomy. Br J Surg 1993;80:1047-50.
19. Gall FP, Hernanek P, Gebhardt CH, Meier H. Erweiterte Resektion der Pankreas und periampullären Karzinome. Regionale, totale und partielle Duodenopankreatektomie. Lever Magen Darm 1981;11:179-84.
20. World Health Organization Expert Committee: Diabetes mellitus. Technical Report Series. Geneva, Switzerland: 1985: No 741.
21. De Fronzo RA, Tobin TD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237(3):E214-32.
22. Heding LG. Radioimmunological determination of human C-peptide in scrum. Diabetologia 1975;11:541-7.
23. Adrian TE, Barnes AJ, Long RG, et al. The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab 1981;53:675-81.
24. van Jaarsveld BC, Hackeng WHL, Niuwenhuis MG, Erkelens DW, Geerdink RA, Lips CJM. Islet-amyloid polypeptide in human plasma. Lancet 1990;1:60.
25. Butler PC, Chou J, Carter WB, et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and non-diabetic humans. Diabetes 1990;39:752-6.
26. Sanke T, Hanabusa T, Nakano Y, Nishimura S, Kondo M, Nanjo K. Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1990;34:129-32.
27. Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B. A glucagonoma syndrome. Lancet 1974;2:1-5.
28. Barnes AJ, Bloom SR. Pancreatectomised man: a model for diabetes without glucagon. Lancet 1976;2:219-21.
29. Barnes AJ, Bloom A, Crowley MF, Tuttlebee JW. Is glucagon important in stable insulin-dependent diabetics? Lancet 1975;2:734-7.
30. Kahn SE, Klaff LJ, Schwartz MW, et al. Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J Clin Endocrinol Metab 1990;71:994-1002.
31. Adrian TE, Uttenthal LO, Williams SJ, Bloom SR. Secretion of pancreatic polypeptide in patients with pancreatic endocrine tumors. N Engl J Med 1986;315:287-91.
32. Layer P, Go VLW, DiMagno EP. Carbohydrate digestion and release of pancreatic polypeptide in health and in diabetes mellitus. Gut 1989;30:1279-84.
33. Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz P, Barnes AJ. Distribution and release of human pancreatic polypeptide. Gut 1976;17:940-4.
34. Schmidt WE, Creutzfeldt W. Pancreastatin - a novel regulatory peptide? Acta Oncol 1991;30:441-9.